NOMAD Power Solutions, Inc. (NMAD) vs Rani Therapeutics Holdings, Inc. (RANI)
A side-by-side comparison of NOMAD Power Solutions, Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NMAD
NOMAD Power Solutions, Inc.
$4.23HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT
RANI
Rani Therapeutics Holdings, Inc.
$0.79HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT
Total return — NMAD vs RANI
growth of $100 · dividends reinvested · last 1yNMAD -39.7% (-39.7%/yr)RANI -7.7% (-7.7%/yr)RANI compounded faster over this window
NMAD RANI
NMAD vs RANI: by the numbers
- •NMAD is the larger company ($52M vs $51M market cap).
- •Both run net losses; NMAD's is the smaller (0.00% vs -618.02% net margin).
Metrics side by side
Valuation
| Metric | NMAD | RANI |
|---|---|---|
| P/S ratio | N/A | 10.52 |
| P/B ratio | 2186.54 | 1.31 |
Profitability
| Metric | NMAD | RANI |
|---|---|---|
| Gross margin | 0.00% | 44.89% |
| Operating margin | 0.00% | -2345.99% |
| Net margin | 0.00% | -618.02% |
| ROE | -36114.03% | -76.82% |
| ROIC | -31665.34% | -63.96% |
Growth (annualized)
| Metric | NMAD | RANI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.95% |
| Total return CAGR (5Y) | N/A | -46.70% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.